Five things to know:
1. Researches included 327 patients who had spinal deformity surgery and five-year follow-up, and published methods helped determine costs based on CMS’s definitions. Cost utility was calculated with quality-adjusted life-years utilizing the Oswestry Disability Index. The cost-effectiveness threshold of $150,000 was used for primary analysis.
2. Major complication rates were 11%, and minor complication rates were 47%, and 26% of the patients had reoperation by five years.
3. Costs associated with one surgery was about $91,000.
4. Nineteen percent of patients met cost-effectiveness at two years after surgery. In cases where revision was avoided, 87% of the patients met cumulative cost-effectiveness until life expectancy.
5. The study concluded that “Most patients achieved cost-effectiveness after four years postoperatively, with 56% meeting at five years postoperatively. When revision was avoided, 87% of patients met cumulative cost-effectiveness till life expectancy. Mechanical complications were predictive of failure to achieve cost-effectiveness at two years, while comorbidity burden and medical complications were at five years.”
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
